Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug

wsj.com/health/pharma/novo-nordisk-says-wegovy-cuts-heart-risk-by-57-compared-with-eli-lillys-obesity-drug-c3353235

This story appeared on wsj.com, 2025-09-01 19:45:50.143000.
The Entire Business World on a Single Page. Free to Use →